Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FL4P6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,573
Award facts
- Contract value 100% obligated
- $41,572.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of XELJANZ XR 11 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $41,572.80 under firm fixed pricing and is scheduled for completion by October 31, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains extensive federal contracting relationships with the Defense Logistics Agency and its Medical Supply Chain across a diverse portfolio of pharmaceutical products and medical supplies. The company's federal procurement activities support critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. XELJANZ XR is a specialty immunosuppressive medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting AmerisourceBergen's role in supplying specialized pharmaceutical commodities to support military medical readiness and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB26FL4P6?
SPE2DB26FL4P6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FL4P6 worth?
The government has obligated $41,573 on SPE2DB26FL4P6.
Is contract SPE2DB26FL4P6 an order under another contract?
Yes. SPE2DB26FL4P6 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL4P6 competed?
The extent of competition for SPE2DB26FL4P6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award